Is ertapenem (a carbapenem β‑lactam) safe to use in a patient allergic to amoxicillin, erythromycin, and sulfonamide antibiotics?

Ertapenem Safety in Patients with Amoxicillin, Erythromycin, and Sulfa Allergies

Yes, ertapenem is safe to use in patients with amoxicillin (penicillin), erythromycin, and sulfonamide allergies without requiring prior testing or additional precautions. 1

Key Recommendation

The 2022 Drug Allergy Practice Parameter explicitly states that carbapenems (including ertapenem) may be administered to patients with a history of penicillin or cephalosporin allergy without testing or additional precautions. 1 This is a conditional recommendation with moderate certainty of evidence.

Breaking Down Each Allergy

Amoxicillin (Penicillin) Allergy

• Cross-reactivity between penicillins and carbapenems is extremely low at 0.87% (95% CI: 0.32-2.32%) 1, 2
• In patients with positive penicillin skin tests (confirmed allergy), only 0.3% experienced a potentially IgE-mediated reaction to carbapenems 1
• A prospective study of 211 patients with skin test-confirmed penicillin allergy showed all tolerated carbapenems 1
• Research specifically on ertapenem showed 35 of 36 β-lactam allergic patients tolerated the full dose 3

Erythromycin Allergy

• No cross-reactivity exists between macrolides (erythromycin) and β-lactams (ertapenem)
• These are completely different antibiotic classes with distinct chemical structures and mechanisms
• This allergy is irrelevant to ertapenem safety

Sulfonamide Allergy

• No cross-reactivity exists between sulfonamide antibiotics and β-lactams (ertapenem)
• These are completely different antibiotic classes
• This allergy is irrelevant to ertapenem safety

Important Caveats

When to Exercise Caution

The guideline notes that carbapenems can be given without prior testing "as long as it is not a severe delayed cutaneous or organ-involved reaction" 1. If the patient's amoxicillin allergy history includes:

• Stevens-Johnson syndrome (SJS)
• Toxic epidermal necrolysis (TEN)
• Drug reaction with eosinophilia and systemic symptoms (DRESS)
• Acute generalized exanthematous pustulosis (AGEP)

Then avoid ertapenem and consult allergy/immunology, as these represent severe T-cell-mediated reactions where cross-reactivity patterns differ.

Special Situations

• In patients with multiple drug allergies or significant anxiety, consider a graded drug challenge 1
• The FDA label confirms that hypersensitivity reactions are possible and requires inquiry about previous β-lactam reactions 4

Clinical Bottom Line

Proceed with ertapenem administration directly in this patient. The amoxicillin allergy poses minimal risk (cross-reactivity <1%), while erythromycin and sulfa allergies are completely unrelated to carbapenem safety. No skin testing or graded challenge is necessary unless the amoxicillin reaction was a severe delayed cutaneous reaction (SJS/TEN/DRESS/AGEP).

Monitor the patient during administration as you would with any antibiotic, but the evidence strongly supports safe use without additional precautions in typical immediate or mild delayed penicillin allergy histories.